Skip to main content
Clinical Trials/NCT05560022
NCT05560022
Withdrawn
Not Applicable

Study of the Total Hip Prosthesis With a HYPE Stem in Hip Arthroplasty

Societe dEtude, de Recherche et de Fabrication2 sites in 1 country180 target enrollmentDecember 5, 2017
ConditionsHip Arthropathy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hip Arthropathy
Sponsor
Societe dEtude, de Recherche et de Fabrication
Enrollment
180
Locations
2
Primary Endpoint
Assess the Survival rate to Total Hip Prothesis combining a HYPE stem and a SERF cup in hip replacements
Status
Withdrawn
Last Updated
8 days ago

Overview

Brief Summary

The purpose of this study is to validate the performance and the safety of the HYPE (SERF) prothesis in compliance with the 93/42/EEC directive and in relation to the recommendations of the MEDDEV 2.7.1 guide ( guideline for post-market follow-up), which provides for the implementation of a systematic procedure for the follow-up of clinical data in order to verify the performance claimed for medical devices .

Registry
clinicaltrials.gov
Start Date
December 5, 2017
End Date
January 20, 2031
Last Updated
8 days ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Societe dEtude, de Recherche et de Fabrication
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Man or women
  • Degenerative or inflammatory hip pathology requiring a total hip replacement
  • Primary or secondary osteoarthritis
  • Advanced joint destruction resulting from rhumatoid arthritis or traumatic arthritis
  • Fracture or avascular necrosis
  • Sub-capital fracture and displaced transcervical as well as for bone defects stages I to IIb of PAPROSKY
  • Traumatic joint destruction
  • Following previous intervention, provided that the new device does not interfere with the material in place (osteosynthesis, joint reconstruction, arthrodesis, hemi-arthroplasty, total arthroplasty

Exclusion Criteria

  • People with diminished mental faculties
  • Known current pregnancy
  • Breast-feeding
  • Neurological disorders or other pathologies that may influence locomotion
  • Septic antecedent on hip to operate
  • Patient requiring a bone graft

Outcomes

Primary Outcomes

Assess the Survival rate to Total Hip Prothesis combining a HYPE stem and a SERF cup in hip replacements

Time Frame: per operative period to 10 years

Survival according to Kaplan Meier

Secondary Outcomes

  • Assess the improvement in PMA scores and HHS score as well as patient satisfaction(per operative period to 10 years)
  • Adverse events(per operative period to 10 years)
  • Patient satisfaction(per operative period to 10 years)

Study Sites (2)

Loading locations...

Similar Trials